Annual Interest Expense
$44.10 M
-$10.70 M-19.53%
31 December 2023
Summary:
Vertex Pharmaceuticals Incorporated annual interest expense is currently $44.10 million, with the most recent change of -$10.70 million (-19.53%) on 31 December 2023. During the last 3 years, it has fallen by -$14.10 million (-24.23%). VRTX annual interest expense is now -47.63% below its all-time high of $84.21 million, reached on 31 December 2015.VRTX Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
$7.50 M
-$2.40 M-24.24%
30 September 2024
Summary:
Vertex Pharmaceuticals Incorporated quarterly interest expense is currently $7.50 million, with the most recent change of -$2.40 million (-24.24%) on 30 September 2024. Over the past year, it has dropped by -$3.40 million (-31.19%). VRTX quarterly interest expense is now -69.13% below its all-time high of $24.30 million, reached on 31 December 2017.VRTX Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
$38.40 M
-$3.40 M-8.13%
30 September 2024
Summary:
Vertex Pharmaceuticals Incorporated TTM interest expense is currently $38.40 million, with the most recent change of -$3.40 million (-8.13%) on 30 September 2024. Over the past year, it has dropped by -$6.70 million (-14.86%). VRTX TTM interest expense is now -54.68% below its all-time high of $84.73 million, reached on 30 September 2015.VRTX TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VRTX Interest Expense Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -19.5% | -31.2% | -14.9% |
| 3 y3 years | -24.2% | -50.7% | -38.8% |
| 5 y5 years | -39.1% | -48.5% | -39.0% |
VRTX Interest Expense High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -28.3% | at low | -50.7% | at low | -38.8% | at low |
| 5 y | 5 years | -39.1% | at low | -54.1% | at low | -39.0% | at low |
| alltime | all time | -47.6% | +234.3% | -69.1% | +7794.7% | -54.7% | +1036.8% |
Vertex Pharmaceuticals Incorporated Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $7.50 M(-24.2%) | $38.40 M(-8.1%) |
| June 2024 | - | $9.90 M(-4.8%) | $41.80 M(-3.0%) |
| Mar 2024 | - | $10.40 M(-1.9%) | $43.10 M(-2.3%) |
| Dec 2023 | $44.10 M(-19.5%) | $10.60 M(-2.8%) | $44.10 M(-2.2%) |
| Sept 2023 | - | $10.90 M(-2.7%) | $45.10 M(-5.8%) |
| June 2023 | - | $11.20 M(-1.8%) | $47.90 M(-6.6%) |
| Mar 2023 | - | $11.40 M(-1.7%) | $51.30 M(-6.4%) |
| Dec 2022 | $54.80 M(-10.9%) | $11.60 M(-15.3%) | $54.80 M(-6.0%) |
| Sept 2022 | - | $13.70 M(-6.2%) | $58.30 M(-2.5%) |
| June 2022 | - | $14.60 M(-2.0%) | $59.80 M(-1.5%) |
| Mar 2022 | - | $14.90 M(-1.3%) | $60.70 M(-1.3%) |
| Dec 2021 | $61.50 M(+5.7%) | $15.10 M(-0.7%) | $61.50 M(-2.0%) |
| Sept 2021 | - | $15.20 M(-1.9%) | $62.74 M(+2.2%) |
| June 2021 | - | $15.50 M(-1.3%) | $61.39 M(+2.7%) |
| Mar 2021 | - | $15.70 M(-3.9%) | $59.76 M(+2.7%) |
| Dec 2020 | $58.20 M(-0.5%) | $16.34 M(+17.9%) | $58.20 M(+3.7%) |
| Sept 2020 | - | $13.86 M(-0.1%) | $56.11 M(-1.2%) |
| June 2020 | - | $13.87 M(-1.9%) | $56.80 M(-1.7%) |
| Mar 2020 | - | $14.14 M(-0.8%) | $57.77 M(-1.3%) |
| Dec 2019 | $58.50 M(-19.3%) | $14.25 M(-2.1%) | $58.50 M(-7.1%) |
| Sept 2019 | - | $14.55 M(-1.9%) | $63.00 M(-6.2%) |
| June 2019 | - | $14.84 M(-0.2%) | $67.14 M(-4.7%) |
| Mar 2019 | - | $14.87 M(-20.7%) | $70.45 M(-2.8%) |
| Dec 2018 | $72.47 M(+4.6%) | $18.74 M(+0.3%) | $72.47 M(-7.1%) |
| Sept 2018 | - | $18.69 M(+2.9%) | $78.02 M(+7.0%) |
| June 2018 | - | $18.16 M(+7.5%) | $72.91 M(+5.0%) |
| Mar 2018 | - | $16.89 M(-30.5%) | $69.42 M(+0.2%) |
| Dec 2017 | $69.30 M(-14.9%) | $24.30 M(+79.0%) | $69.30 M(+5.9%) |
| Sept 2017 | - | $13.57 M(-7.4%) | $65.44 M(-9.1%) |
| June 2017 | - | $14.66 M(-12.5%) | $72.01 M(-7.1%) |
| Mar 2017 | - | $16.77 M(-18.0%) | $77.50 M(-4.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2016 | $81.43 M(-3.3%) | $20.44 M(+1.5%) | $81.43 M(-0.3%) |
| Sept 2016 | - | $20.14 M(-0.1%) | $81.65 M(-1.2%) |
| June 2016 | - | $20.16 M(-2.6%) | $82.64 M(-1.1%) |
| Mar 2016 | - | $20.70 M(+0.2%) | $83.60 M(-0.7%) |
| Dec 2015 | $84.21 M(+15.6%) | $20.65 M(-2.3%) | $84.21 M(-0.6%) |
| Sept 2015 | - | $21.13 M(+0.1%) | $84.73 M(+0.9%) |
| June 2015 | - | $21.11 M(-0.9%) | $83.98 M(+7.0%) |
| Mar 2015 | - | $21.31 M(+0.6%) | $78.45 M(+7.7%) |
| Dec 2014 | $72.86 M(+217.8%) | $21.18 M(+3.9%) | $72.86 M(+13.0%) |
| Sept 2014 | - | $20.38 M(+30.8%) | $64.50 M(+45.9%) |
| June 2014 | - | $15.59 M(-0.8%) | $44.21 M(+25.7%) |
| Mar 2014 | - | $15.72 M(+22.6%) | $35.18 M(+53.4%) |
| Dec 2013 | $22.93 M(+52.4%) | $12.82 M(>+9900.0%) | $22.93 M(+126.8%) |
| Sept 2013 | - | $95.00 K(-98.5%) | $10.11 M(+0.9%) |
| June 2013 | - | $6.55 M(+89.1%) | $10.02 M(+189.1%) |
| Mar 2013 | - | $3.46 M(-15.5%) | $3.46 M(-88.4%) |
| Dec 2012 | $15.04 M(-60.1%) | - | - |
| Mar 2012 | - | $4.10 M(-64.8%) | $29.78 M(-21.0%) |
| Dec 2011 | $37.68 M(+95.5%) | $11.66 M(+65.2%) | $37.68 M(+11.8%) |
| Sept 2011 | - | $7.06 M(+1.4%) | $33.71 M(+10.2%) |
| June 2011 | - | $6.96 M(-42.0%) | $30.60 M(+12.0%) |
| Mar 2011 | - | $12.00 M(+56.1%) | $27.32 M(+41.7%) |
| Dec 2010 | $19.27 M(+46.1%) | $7.69 M(+94.5%) | $19.27 M(+19.3%) |
| Sept 2010 | - | $3.95 M(+7.3%) | $16.15 M(+14.3%) |
| June 2010 | - | $3.68 M(-6.9%) | $14.13 M(+2.6%) |
| Mar 2010 | - | $3.96 M(-13.3%) | $13.77 M(+4.4%) |
| Dec 2009 | $13.19 M(-2.1%) | $4.56 M(+136.7%) | $13.19 M(+52.9%) |
| Sept 2009 | - | $1.93 M(-42.0%) | $8.63 M(+28.7%) |
| June 2009 | - | $3.33 M(-1.6%) | $6.70 M(+98.4%) |
| Mar 2009 | - | $3.38 M | $3.38 M |
| Dec 2008 | $13.47 M | - | - |
FAQ
- What is Vertex Pharmaceuticals Incorporated annual interest expense?
- What is the all time high annual interest expense for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated annual interest expense year-on-year change?
- What is Vertex Pharmaceuticals Incorporated quarterly interest expense?
- What is the all time high quarterly interest expense for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated quarterly interest expense year-on-year change?
- What is Vertex Pharmaceuticals Incorporated TTM interest expense?
- What is the all time high TTM interest expense for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated TTM interest expense year-on-year change?
What is Vertex Pharmaceuticals Incorporated annual interest expense?
The current annual interest expense of VRTX is $44.10 M
What is the all time high annual interest expense for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high annual interest expense is $84.21 M
What is Vertex Pharmaceuticals Incorporated annual interest expense year-on-year change?
Over the past year, VRTX annual interest expense has changed by -$10.70 M (-19.53%)
What is Vertex Pharmaceuticals Incorporated quarterly interest expense?
The current quarterly interest expense of VRTX is $7.50 M
What is the all time high quarterly interest expense for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high quarterly interest expense is $24.30 M
What is Vertex Pharmaceuticals Incorporated quarterly interest expense year-on-year change?
Over the past year, VRTX quarterly interest expense has changed by -$3.40 M (-31.19%)
What is Vertex Pharmaceuticals Incorporated TTM interest expense?
The current TTM interest expense of VRTX is $38.40 M
What is the all time high TTM interest expense for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high TTM interest expense is $84.73 M
What is Vertex Pharmaceuticals Incorporated TTM interest expense year-on-year change?
Over the past year, VRTX TTM interest expense has changed by -$6.70 M (-14.86%)